|
Real-time Estimate
Cboe BZX
20:28:39 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.860 USD | -3.74% |
|
+6.16% | -45.27% |
Company Valuation: Bicycle Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,790 | 878.8 | 767 | 966.6 | 491.1 | 280.7 | - | - |
| Change | - | -50.89% | -12.72% | 26.03% | -49.19% | -42.85% | - | - |
| Enterprise Value (EV) 1 | 1,381 | 570 | 280.6 | 91.11 | -122.9 | -232.1 | -122.7 | -4.095 |
| Change | - | -58.72% | -50.76% | -67.53% | -234.87% | -88.9% | 47.15% | 96.66% |
| P/E | -22.8x | -7.79x | -3.56x | -4.83x | -2.24x | -1.54x | -1.71x | -1.52x |
| PBR | 4.41x | 3.24x | 2.07x | 1.03x | 0.81x | 0.5x | 0.6x | 0.73x |
| PEG | - | -0.2x | -0.1x | 0.1x | -0.25x | 0.1x | 0.2x | -0.1x |
| Capitalization / Revenue | 153x | 60.8x | 28.4x | 27.4x | 6.77x | 16x | 42x | 18x |
| EV / Revenue | 118x | 39.4x | 10.4x | 2.58x | -1.69x | -13.2x | -18.3x | -0.26x |
| EV / EBITDA | -21.5x | -5.05x | -1.53x | -0.45x | 0.51x | 1.68x | 0.71x | 0.02x |
| EV / EBIT | -21x | -4.89x | -1.48x | -0.43x | 0.5x | 1.24x | 0.65x | 0.02x |
| EV / FCF | -82.1x | -5.42x | -4.42x | -0.55x | 0.49x | 1.52x | 0.84x | 0.03x |
| FCF Yield | -1.22% | -18.4% | -22.6% | -182% | 205% | 65.9% | 119% | 3,712% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.67 | -3.8 | -5.08 | -2.9 | -3.16 | -2.602 | -2.341 | -2.641 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 11.7 | 14.46 | 26.98 | 35.28 | 72.59 | 17.53 | 6.689 | 15.61 |
| EBITDA 1 | -64.21 | -113 | -183.4 | -202.7 | -240.6 | -138.5 | -172.9 | -172.9 |
| EBIT 1 | -65.62 | -116.7 | -189.9 | -209.9 | -247.1 | -187.2 | -190.1 | -209.9 |
| Net income 1 | -66.82 | -112.7 | -180.7 | -169 | -219 | -172.1 | -175.1 | -199 |
| Net Debt 1 | -408.8 | -308.8 | -486.3 | -875.5 | -614 | -512.8 | -403.4 | -284.8 |
| Reference price 2 | 60.870 | 29.600 | 18.080 | 14.000 | 7.080 | 4.010 | 4.010 | 4.010 |
| Nbr of stocks (in thousands) | 29,400 | 29,689 | 42,422 | 69,046 | 69,368 | 69,993 | - | - |
| Announcement Date | 01/03/22 | 28/02/23 | 20/02/24 | 25/02/25 | 17/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54x | -13.24x | 1.68x | - | 281M | |
| 21.73x | 7.72x | 15.51x | 1.37% | 74.31B | |
| 29.59x | 8.5x | 26.48x | 0.04% | 56.95B | |
| 33.52x | 6.02x | 18.04x | 0.97% | 48.3B | |
| -21.51x | 223.61x | -23.09x | -.--% | 44.51B | |
| 34.27x | 3.31x | 14.29x | -.--% | 43.8B | |
| 47.24x | 5.47x | 29.99x | -.--% | 41.12B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 31.07B | |
| 33.5x | 7.16x | 18.6x | -.--% | 28.97B | |
| -15.28x | 5.82x | -7.31x | -.--% | 24.53B | |
| Average | 18.92x | 26.23x | 11.47x | 0.31% | 39.38B | |
| Weighted average by Cap. | 22.50x | 31.14x | 13.61x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BCYC Stock
- Valuation Bicycle Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
